Celltrion
068270.KS
$129.16
Share price
-1.17%
Change (1 day)
3.12%
Change (1 year)
Categories
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
Celltrion (068270.KS) - Net assets
Net assets on the balance sheet as of December 2023 : $13.23 B
According to Celltrion
's latest financial reports the company has $13.23 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Celltrion - Net assets on balance sheet (from 2007 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $3.38 B | -0.42% |
| 2021-12-31 | $3.40 B | 7.89% |
| 2020-12-31 | $3.15 B | 26.99% |
| 2019-12-31 | $2.48 B | 6.86% |
| 2018-12-31 | $2.32 B | 2.82% |
| 2017-12-31 | $2.26 B | 32.26% |
| 2016-12-31 | $1.70 B | 18.02% |
| 2015-12-31 | $1.44 B | 17.73% |
| 2014-12-31 | $1.23 B | 19.34% |
| 2013-12-31 | $1.03 B | 1.93% |
| 2012-12-31 | $1.01 B | 30.38% |
| 2011-12-31 | $0.77 B | 12.13% |
| 2010-12-31 | $0.69 B | 178.81% |
| 2009-12-31 | $0.24 B | 40.31% |
| 2008-12-31 | $0.17 B | 516.22% |
| 2007-12-31 | $28.7 M |